Phibro Animal Health Corporation PAHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 35.97% | -9.63% | -12.51% | 3.51% | 54.01% |
| Total Depreciation and Amortization | 14.85% | -5.03% | -3.44% | 0.48% | 16.74% |
| Total Amortization of Deferred Charges | -70.95% | 271.33% | 0.00% | 0.00% | -71.30% |
| Total Other Non-Cash Items | 386.34% | -130.68% | 67.03% | 20.62% | -45.22% |
| Change in Net Operating Assets | -133.48% | 63.45% | -6.47% | 25.21% | -135.31% |
| Cash from Operations | 8.25% | 48.67% | -16.26% | 108.04% | -56.27% |
| Capital Expenditure | 0.46% | -23.20% | -38.02% | 19.62% | -5.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 430.81% | 262.28% | 75.52% | 15.55% | -1,049.67% |
| Cash from Investing | 63.85% | 2.11% | 2.20% | 18.23% | -198.75% |
| Total Debt Issued | 76.52% | 15.63% | 17.74% | -27.91% | 42.08% |
| Total Debt Repaid | -85.83% | -14.42% | 7.47% | -17.46% | -2.16% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.10% | 0.02% | -0.08% | 0.00% | 0.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -248.85% | 29.78% | 87.88% | -216.19% | 310.34% |
| Foreign Exchange rate Adjustments | -180.52% | -80.28% | 597.45% | -540.19% | -91.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.70% | 1,265.17% | 96.78% | -465.39% | -38.45% |